SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-040385
Filing Date
2022-07-20
Accepted
2022-07-19 19:43:13
Documents
16
Period of Report
2022-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea163069-8k_inmedpharma.htm   iXBRL 8-K 27889
2 EMPLOYMENT AGREEMENT DATED JULY 15, 2022, BETWEEN INMED PHARMACEUTICALS INC. AND ea163069ex10-1_inmedpharma.htm EX-10.1 214019
3 PRESS RELEASE, DATED JULY 18, 2022 ea163069ex99-1_inmedpharma.htm EX-99.1 7606
4 GRAPHIC ex10-1_001.jpg GRAPHIC 5766
5 GRAPHIC ex99-1_001.jpg GRAPHIC 51400
  Complete submission text file 0001213900-22-040385.txt   545821

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20220715.xsd EX-101.SCH 2965
7 XBRL LABEL FILE inm-20220715_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE inm-20220715_pre.xml EX-101.PRE 22364
10 EXTRACTED XBRL INSTANCE DOCUMENT ea163069-8k_inmedpharma_htm.xml XML 3612
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221092557
SIC: 2834 Pharmaceutical Preparations